Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07566884Not ApplicableActive Not Recruiting

Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults

Role: collaborator

NCT06157736Recruiting

Microbiome in the Acute Stage of New Onset Paediatric Type 1 Diabetes

Role: collaborator

NCT06311097Not ApplicableRecruiting

Dairy Products to Your Gut and Brain

Role: collaborator

All 3 trials loaded